GU Cancers Symp. 2014: Bladder Cancer

GU Cancers Symposium 2014 - Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer analysis - Poster February 4, 2014

GU Cancers Symposium 2014 - Premature termination of genitourinary cancer clinical trials - Poster February 4, 2014

GU Cancers Symposium 2014 - NeuACT, a phase II, randomized, open-label trial of DN24-02: Updated analysis of HER2 expression, immune responses, product parameters, and safety in patients with surgically resected HER2+ urothelial cancer - Poster February 4, 2014

GU Cancers Symposium 2014 - A decade in review: Building blocks in the progress in management of urothelial carcinomas - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - Premature termination of genitourinary cancer clinical trials - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - The initial report of RTOG 0524: Phase I/II trial of a combination of paclitaxel and trastuzumab with daily irradiation or paclitaxel alone with daily irradiation following transurethral surgery... February 3, 2014

GU Cancers Symposium 2014 - Evaluation of outcomes following centralization of cystectomy services in the United Kingdom - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - Biology of bladder cancer metastases - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer analysis - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - The Cancer Genome Atlas (TCGA) bladder cancer update - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Next generation sequencing technologies: Advancing therapy for urothelial carcinoma - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Preclinical models for bladder cancer - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Multimodal management of urothelial carcinoma - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - A pooled analysis of RTOG 9906 and 0233 - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Update on European Organisation for Research and Treatment of Cancer (EORTC) guidelines for bladder cancer - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Practical use of molecular markers in the management of bladder cancer - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Premature termination of genitourinary cancer clinical trials - Slide Presentation January 28, 2014